Here’s a **comprehensive, high-level, structured, and elegant summary of *Pulmonary Thromboembolism (PTE)*** — formatted in a clear, professional, and educational style suitable for notes, articles, or presentations. --- ## 🫁 **Pulmonary Thromboembolism (PTE)** ### **Definition** Pulmonary thromboembolism refers to the **obstruction of the pulmonary arterial circulation** by a thrombus (blood clot) that has **embolized**, most commonly from the **deep veins of the lower limbs** (deep vein thrombosis, DVT). --- ### **Etiology / Causes** Most cases arise from **venous thromboembolism (VTE)** due to: * **Deep vein thrombosis (DVT)** — femoral, iliac, or popliteal veins (most common) * Thrombi from pelvic veins, right heart chambers (in atrial fibrillation) * Rare: Fat, air, tumor, septic emboli, amniotic fluid --- ### **Predisposing / Risk Factors** (Collectively summarized by **Virchow’s Triad**) #### 1️⃣ Venous Stasis * Prolonged immobilization (bed rest, long flights) * Heart failure * Obesity * Varicose veins #### 2️⃣ Endothelial Injury * Trauma, surgery * Central venous catheters * Previous DVT #### 3️⃣ Hypercoagulable State * Inherited: Factor V Leiden mutation, Protein C/S deficiency, Antithrombin III deficiency * Acquired: Pregnancy, oral contraceptives, malignancy, antiphospholipid syndrome --- ### **Pathophysiology** * A thrombus dislodges → travels via the venous system → reaches the **right side of the heart** → enters **pulmonary artery** → causes **vascular obstruction**. * Effects: * ↑ Pulmonary vascular resistance → **acute pulmonary hypertension** * Impaired gas exchange → **V/Q mismatch** → hypoxemia * Decreased cardiac output due to right ventricular strain → possible **cardiogenic shock** --- ### **Clinical Features** #### 🩺 **Symptoms** * Sudden onset **dyspnea (shortness of breath)** * **Pleuritic chest pain** * **Cough** ± **hemoptysis** * **Syncope** (in massive embolism) #### 👀 **Signs** * Tachypnea, tachycardia * Cyanosis * Hypotension (in massive PTE) * Raised JVP, loud P₂ (pulmonary component of 2nd heart sound) * Signs of DVT in lower limb: swelling, tenderness, redness --- ### **Classification** 1. **By size/location:** * Massive PTE (>50% pulmonary circulation obstructed) * Submassive PTE (right ventricular dysfunction without hypotension) * Small/Segmental or Subsegmental emboli 2. **By onset:** * Acute * Chronic (leading to **chronic thromboembolic pulmonary hypertension**, CTEPH) --- ### **Investigations** #### 🔬 **Laboratory Tests** * **D-dimer**: Elevated (sensitive but not specific) * **Arterial blood gases (ABG)**: Hypoxemia, respiratory alkalosis * **Cardiac enzymes (Troponin, BNP)**: Elevated in right ventricular strain #### 🖥️ **Imaging** * **CT Pulmonary Angiography (CTPA)**: *Gold standard* — visualizes thrombus directly * **Ventilation/Perfusion (V/Q) Scan**: For patients unable to undergo CT * **Doppler Ultrasound** of lower limbs: Detects DVT source * **Echocardiography**: Right ventricular dysfunction or thrombus in right heart * **Chest X-ray**: Often normal; may show: * Hampton’s hump (wedge-shaped infarct) * Westermark’s sign (oligemia) * Palla’s sign (enlarged pulmonary artery) #### **ECG Findings** * Sinus tachycardia (most common) * S₁Q₃T₃ pattern (classic but uncommon) * Right axis deviation, right bundle branch block --- ### **Diagnosis** * **Clinical probability scoring systems:** * **Wells Score** * **Revised Geneva Score** * Combined with **D-dimer** and **CTPA** for confirmation --- ### **Complications** * Pulmonary infarction * Right heart failure * Recurrent emboli * **Chronic Thromboembolic Pulmonary Hypertension (CTEPH)** * Sudden death (in massive embolism) --- ### **Management** #### 🏥 **Acute Phase** 1. **Supportive Care** * Oxygen therapy * IV fluids cautiously (avoid right ventricular overload) * Vasopressors (if hypotension) 2. **Anticoagulation (mainstay)** * Low Molecular Weight Heparin (LMWH) * Unfractionated Heparin (UFH) — in renal impairment * Transition to Oral Anticoagulants: * Warfarin (INR 2–3) * Direct Oral Anticoagulants (DOACs): Apixaban, Rivaroxaban, Dabigatran 3. **Thrombolytic Therapy** * Indicated for **massive PE** with hemodynamic instability * Agents: Alteplase (tPA), Streptokinase, Urokinase 4. **Surgical / Catheter Intervention** * Embolectomy * Catheter-directed thrombolysis * Inferior vena cava (IVC) filter (if anticoagulation contraindicated) --- ### **Long-term Management** * Continue anticoagulation for 3–6 months or lifelong (if recurrent or unprovoked) * Monitor INR (if on Warfarin) * Encourage mobility, compression stockings * Manage underlying risk factors --- ### **Prevention** * Early mobilization after surgery or trauma * Prophylactic LMWH or heparin in high-risk patients * Graduated compression stockings * Avoid dehydration, prolonged immobilization --- ### **Prognosis** * Mortality: ~30% if untreated; <10% with prompt treatment * Prognostic indicators: Extent of embolism, right ventricular dysfunction, comorbidities --- ### **Key Summary Table** | **Aspect** | **Details** | | --------------------- | ---------------------------------- | | **Origin** | DVT (lower limb veins) | | **Main symptoms** | Dyspnea, chest pain, hemoptysis | | **Key investigation** | CT Pulmonary Angiography | | **Main treatment** | Anticoagulation ± Thrombolysis | | **Complication** | Right heart failure, CTEPH | | **Prevention** | Early ambulation, LMWH prophylaxis | --- ### 🧠 **Mnemonic: “SADDLE” for Pulmonary Embolism Red Flags** * **S** – Sudden dyspnea * **A** – Anxiety, apprehension * **D** – Dyspnea, chest pain * **D** – D-dimer ↑ * **L** – Low O₂ saturation * **E** – ECG S₁Q₃T₃ pattern --- Would you like me to make this into a **beautiful HTML page (with CSS & responsive design)** — e.g., for a **medical education website or digital note** version?